Literature DB >> 31344387

Epigenetic regulation of POMC; implications for nutritional programming, obesity and metabolic disease.

T Candler1, P Kühnen2, A M Prentice3, M Silver3.   

Abstract

Proopiomelanocortin (POMC) is a key mediator of satiety. Epigenetic marks such as DNA methylation may modulate POMC expression and provide a biological link between early life exposures and later phenotype. Animal studies suggest epigenetic marks at POMC are influenced by maternal energy excess and restriction, prenatal stress and Triclosan exposure. Postnatal factors including energy excess, folate, vitamin A, conjugated linoleic acid and leptin may also affect POMC methylation. Recent human studies suggest POMC DNA methylation is influenced by maternal nutrition in early pregnancy and associated with childhood and adult obesity. Studies in children propose a link between POMC DNA methylation and elevated lipids and insulin, independent of body habitus. This review brings together evidence from animal and human studies and suggests that POMC is sensitive to nutritional programming and is associated with a wide range of weight-related and metabolic outcomes.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNA methylation; DOHaD; Epigenetics; Glucose; Insulin; Lipids; Nutrition; Obesity; POMC; Transgenerational

Mesh:

Substances:

Year:  2019        PMID: 31344387     DOI: 10.1016/j.yfrne.2019.100773

Source DB:  PubMed          Journal:  Front Neuroendocrinol        ISSN: 0091-3022            Impact factor:   8.606


  9 in total

1.  A history of opioid exposure in females increases the risk of metabolic disorders in their future male offspring.

Authors:  Anika M Toorie; Fair M Vassoler; Fangfang Qu; Christopher M Schonhoff; Steven Bradburn; Christopher A Murgatroyd; Donna K Slonim; Elizabeth M Byrnes
Journal:  Addict Biol       Date:  2019-11-28       Impact factor: 4.280

Review 2.  Metabolic regulation of kisspeptin - the link between energy balance and reproduction.

Authors:  Víctor M Navarro
Journal:  Nat Rev Endocrinol       Date:  2020-05-19       Impact factor: 43.330

Review 3.  Animal Foetal Models of Obesity and Diabetes - From Laboratory to Clinical Settings.

Authors:  Emilia Grzęda; Julia Matuszewska; Kamil Ziarniak; Anna Gertig-Kolasa; Izabela Krzyśko-Pieczka; Bogda Skowrońska; Joanna H Sliwowska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-07       Impact factor: 5.555

4.  The Systematic Analysis of Exercise Mechanism in Human Diseases.

Authors:  Lei Pu; Peng Sun
Journal:  Genet Res (Camb)       Date:  2022-03-24       Impact factor: 1.588

5.  Tuina combined with diet and exercise for simple obesity: A protocol for systematic review.

Authors:  Lili Chen; Deyu Cong; Gaofeng Wang; Jiabao Sun; Yuanyuan Ji; Zhen Zhong; Tong Liu; Jiayi Liu; Yunjie Chu; Xingquan Wu
Journal:  Medicine (Baltimore)       Date:  2022-02-11       Impact factor: 1.817

Review 6.  Update on the pathogenesis and genetics of Paget's disease of bone.

Authors:  Luigi Gennari; Domenico Rendina; Daniela Merlotti; Guido Cavati; Christian Mingiano; Roberta Cosso; Maria Materozzi; Filippo Pirrotta; Veronica Abate; Marco Calabrese; Alberto Falchetti
Journal:  Front Cell Dev Biol       Date:  2022-08-12

Review 7.  The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits.

Authors:  Anke Hinney; Antje Körner; Pamela Fischer-Posovszky
Journal:  Nat Rev Endocrinol       Date:  2022-07-28       Impact factor: 47.564

Review 8.  Effects of the POMC System on Glucose Homeostasis and Potential Therapeutic Targets for Obesity and Diabetes.

Authors:  Dan Yang; Xintong Hou; Guimei Yang; Mengnan Li; Jian Zhang; Minmin Han; Yi Zhang; Yunfeng Liu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-09-25       Impact factor: 3.249

Review 9.  Food Addiction and Psychosocial Adversity: Biological Embedding, Contextual Factors, and Public Health Implications.

Authors:  David A Wiss; Nicole Avena; Mark Gold
Journal:  Nutrients       Date:  2020-11-16       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.